Gantra 2.5 mg Tablet 14's is used to manage Systolic heart failure to reduce mortality and hospitalizations. It contains Vericiguat, which relaxes the blood vessels in the lungs to allow blood to flow easily. This medication can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant while undergoing therapy and for one month after the treatment. Using effective contraceptive methods is recommended while in therapy with it. Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment.
